Mesenchymal stem cells (MSCs) have recently made significant progress with multiple
clinical trials targeting modulation of immune responses, regeneration of bone, cartilage …

Existing methods for human induced pluripotent stem cell (hiPSC) cardiac differentiation are
efficient but require complex, undefined medium constituents that hinder further elucidation …

This review describes recent developments regarding the use of natural and synthetic
polymers to support the propagation of human pluripotent stem cells (hPSCs), human …

A variety of microcarriers may be used for the expansion of human embryonic stem cells
(hESC) for cell therapy applications. This study investigated the effects of 10 types of …

The tentative clinical application of human pluripotent stem cells (hPSCs), such as human
embryonic stem cells and human induced pluripotent stem cells, is restricted by the …

A prerequisite for the realization of human pluripotent stem cell (hPSC) therapies is the
development of bioprocesses for generating clinically relevant quantities of undifferentiated …

While defining the environment for human embryonic stem cell (hESC) culture on 2-
dimensional (2D) surfaces has made rapid progress, the industrial-scale implementation of …

Regeneration of injured human heart muscle is limited and an unmet clinical need. There
are no methods for the reproducible generation of clinical-quality stem cell-derived …

Establishing cultures of human embryonic (ES) and induced pluripotent (iPS) stem cells in
xeno-free conditions is essential for producing clinical-grade cells. Development of cell …

The term “cell adhesion” represents cell–cell interactions and the interaction between the
cell and the extracellular matrix (ECM). These interactions are crucial for the development of …